Elfgen, Anne
Hupert, Michelle
Bochinsky, Kevin
Tusche, Markus http://orcid.org/0000-0003-0530-7469
González de San Román Martin, Estibaliz
Gering, Ian
Sacchi, Silvia http://orcid.org/0000-0002-2338-2561
Pollegioni, Loredano http://orcid.org/0000-0003-1733-7243
Huesgen, Pitter F. http://orcid.org/0000-0002-0335-2242
Hartmann, Rudolf http://orcid.org/0000-0001-7807-6273
Santiago-Schübel, Beatrix
Kutzsche, Janine
Willbold, Dieter http://orcid.org/0000-0002-0065-7366
Article History
Received: 5 June 2018
Accepted: 20 March 2019
First Online: 5 April 2019
Competing Interests
: D.W. is co-inventor of patents covering the composition of matter of RD2, which was used in the present study. D.W. is also co-founder and co-owner of the company “Priavoid GmbH”, which is developing RD2 further for clinical use. This did not have influence on any data evaluation or its interpretation. All other authors declare no competing interests.